Technical Analysis for LNTH - Lantheus Holdings, Inc.

Grade Last Price % Change Price Change
grade B 23.62 -5.90% -1.48
LNTH closed down 5.9 percent on Friday, March 22, 2019, on 72 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Up Up Down
See historical LNTH trend table...

Date Alert Name Type % Chg
Mar 22 Fell Below 20 DMA Bearish 0.00%
Mar 22 1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Mar 22 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 22 Bollinger Band Squeeze Range Contraction 0.00%
Mar 22 BB Squeeze + Upper Band Touch Range Contraction 0.00%
Mar 22 Upper Bollinger Band Touch Strength 0.00%
Mar 21 New 52 Week Closing High Bullish -5.90%
Mar 21 180 Bullish Setup Bullish Swing Setup -5.90%
Mar 21 Bollinger Band Squeeze Range Contraction -5.90%
Mar 21 BB Squeeze + Upper Band Touch Range Contraction -5.90%

Older signals for LNTH ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Lantheus Holdings, Inc. is engaged in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases. The Company's medical imaging agents are used to diagnose coronary artery disease, congestive heart failure, stroke, peripheral vascular disease and other diseases. The Company's products include contrast agents and medical radiopharmaceuticals, including technetium generators. The Company's products include DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, Neurolite, Thallium Tl 201, Gallium Ga 67, Gludef, Quadramet and Ablavar. The Company is also engaged in developing agents, such as Flurpiridaz F 18, which is a myocardial perfusion imaging agent; 18F LMI 1195, which is a cardiac neuronal imaging agent, and LMI 1174, which is a vascular remodeling imaging agent.
Medicine Chemistry Diseases Chemical Elements Medical Imaging Medical Physics Coronary Artery Disease Peripheral Vascular Disease Medicinal Radiochemistry Radiopharmaceuticals Stroke Congestive Heart Failure Cardiovascular And Other Diseases F 18
Is LNTH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 25.49
52 Week Low 12.59
Average Volume 295,342
200-Day Moving Average 16.2387
50-Day Moving Average 20.1022
20-Day Moving Average 23.729
10-Day Moving Average 24.18
Average True Range 0.9738
ADX 50.19
+DI 34.0751
-DI 12.0021
Chandelier Exit (Long, 3 ATRs ) 22.5686
Chandelier Exit (Short, 3 ATRs ) 24.6414
Upper Bollinger Band 24.9903
Lower Bollinger Band 22.4677
Percent B (%b) 0.46
BandWidth 10.630874
MACD Line 1.1877
MACD Signal Line 1.3625
MACD Histogram -0.1748
Fundamentals Value
Market Cap 882.2 Million
Num Shares 37.3 Million
EPS 0.73
Price-to-Earnings (P/E) Ratio 32.36
Price-to-Sales 2.17
Price-to-Book 0.00
PEG Ratio 0.69
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 26.04
Resistance 3 (R3) 26.29 25.75 25.63
Resistance 2 (R2) 25.75 25.13 25.62 25.50
Resistance 1 (R1) 24.68 24.75 24.41 24.43 25.36
Pivot Point 24.14 24.14 24.00 24.01 24.14
Support 1 (S1) 23.07 23.52 22.80 22.82 21.88
Support 2 (S2) 22.53 23.14 22.40 21.74
Support 3 (S3) 21.46 22.53 21.61
Support 4 (S4) 21.21